Integrating immunopeptidomics and mRNA technology to tackle antimicrobial resistance

“Thus, using immunopeptidomics, we are able not only to identify potential vaccine targets but also to prioritize them.”

Charlotte Barker (Editor, Vaccine Insights) speaks to Francis Impens (Group Leader at VIB and Professor at Ghent University) about how advances in proteomics are being applied to antigen discovery for mRNA vaccines against intracellular, antibiotic-resistant bacterial pathogens.

Please enter your email to access content Read now